{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:42:56Z","timestamp":1794411776491,"version":"4.9.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increasing evidence suggests that besides mutational and molecular alterations, the immune component of the tumor microenvironment also substantially impacts tumor behavior and complicates treatment response, particularly to immunotherapies. Although the standard method for characterizing tumor immune profile is through performing integrated genomic analysis on tissue biopsies, the dynamic change in the immune composition of the tumor microenvironment makes this approach not feasible, especially for brain tumors. Radiomics is a rapidly growing field that uses advanced imaging techniques and computational algorithms to extract numerous quantitative features from medical images. Recent advances in machine learning methods are facilitating biological validation of radiomic signatures and allowing them to \u201cmine\u201d for a variety of significant correlates, including genetic, immunologic, and histologic data. Radiomics has the potential to be used as a non-invasive approach to predict the presence and density of immune cells within the microenvironment, as well as to assess the expression of immune-related genes and pathways. This information can be essential for patient stratification, informing treatment decisions and predicting patients\u2019 response to immunotherapies. This is particularly important for tumors with difficult surgical access such as gliomas. In this review, we provide an overview of the glioma microenvironment, describe novel approaches for clustering patients based on their tumor immune profile, and discuss the latest progress on utilization of radiomics for immune profiling of glioma based on current literature.<\/jats:p>","DOI":"10.1038\/s41698-023-00413-9","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T02:02:09Z","timestamp":1687140129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Radiomics for characterization of the glioma immune microenvironment"],"prefix":"10.1038","volume":"7","author":[{"given":"Nastaran","family":"Khalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita Fathi","family":"Kazerooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Familiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Koptyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip B.","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-4552","authenticated-orcid":false,"given":"Ali","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"413_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller, K. D. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J. Clin. 71, 381\u2013406 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"413_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang, K. et al. Glioma targeted therapy: insight into future of molecular approaches. Mol. Cancer 21, 39 (2022).","journal-title":"Mol. Cancer"},{"key":"413_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56473-0","volume":"9","author":"H Taghizadeh","year":"2019","unstructured":"Taghizadeh, H. et al. Applied precision cancer medicine in neuro-oncology. Sci. Rep. 9, 20139 (2019).","journal-title":"Sci. Rep."},{"key":"413_CR4","doi-asserted-by":"publisher","first-page":"679425","DOI":"10.3389\/fimmu.2021.679425","volume":"12","author":"A Ghouzlani","year":"2021","unstructured":"Ghouzlani, A. et al. Immune checkpoint inhibitors in human glioma microenvironment. Front. Immunol. 12, 679425 (2021).","journal-title":"Front. Immunol."},{"key":"413_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ijms22010351","volume":"22","author":"A Ou","year":"2020","unstructured":"Ou, A., Yung, W. K. A. & Majd, N. Molecular mechanisms of treatment resistance in glioblastoma. Int. J. Mol. Sci. 22, 351 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"413_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/cells10092257","volume":"10","author":"M Dapash","year":"2021","unstructured":"Dapash, M., Hou, D., Castro, B., Lee-Chang, C. & Lesniak, M. S. The interplay between glioblastoma and its microenvironment. Cells 10, 2257 (2021).","journal-title":"Cells"},{"key":"413_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fimmu.2020.01402","volume":"11","author":"S DeCordova","year":"2020","unstructured":"DeCordova, S. et al. Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma. Front. Immunol. 11, 1402 (2020).","journal-title":"Front. Immunol."},{"key":"413_CR8","doi-asserted-by":"publisher","first-page":"e149258","DOI":"10.1172\/JCI149258","volume":"132","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J. Clin. Invest. 132, e149258 (2022).","journal-title":"J. Clin. Invest."},{"key":"413_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-9773-2_12","volume":"2055","author":"CC Smith","year":"2020","unstructured":"Smith, C. C. et al. Using RNA sequencing to characterize the tumor microenvironment. Methods Mol. Biol. 2055, 245\u2013272 (2020).","journal-title":"Methods Mol. Biol."},{"key":"413_CR10","first-page":"20190001","volume":"5","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Immune response in glioma\u2019s microenvironment. Innov. Surg. Sci. 5, 20190001 (2020).","journal-title":"Innov. Surg. Sci."},{"key":"413_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"413_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s42256-021-00377-0","volume":"3","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Radiological tumor classification across imaging modality and histology. Nat. Mach. Intell. 3, 787\u2013798 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"413_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00205-z","volume":"5","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients. NPJ Precis. Oncol. 5, 72 (2021).","journal-title":"NPJ Precis. Oncol."},{"key":"413_CR14","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.3390\/cancers13235921","volume":"13","author":"A Fathi Kazerooni","year":"2021","unstructured":"Fathi Kazerooni, A. et al. Applications of radiomics and radiogenomics in high-grade gliomas in the era of precision medicine. Cancers 13, 5921 (2021).","journal-title":"Cancers"},{"key":"413_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"413_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. & Joyce, J. A. The microenvironmental landscape of brain tumors. Cancer Cell 31, 326\u2013341 (2017).","journal-title":"Cancer Cell"},{"key":"413_CR17","doi-asserted-by":"publisher","first-page":"486912","DOI":"10.1155\/2013\/486912","volume":"2013","author":"BC Kennedy","year":"2013","unstructured":"Kennedy, B. C. et al. Tumor-associated macrophages in glioma: friend or foe? J. Oncol. 2013, 486912 (2013).","journal-title":"J. Oncol."},{"key":"413_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/nov272","volume":"18","author":"JH Stafford","year":"2016","unstructured":"Stafford, J. H. et al. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. Neuro. Oncol. 18, 797\u2013806 (2016).","journal-title":"Neuro. Oncol."},{"key":"413_CR19","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1038\/bjc.2014.162","volume":"110","author":"S Han","year":"2014","unstructured":"Han, S. et al. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br. J. Cancer 110, 2560\u20132568 (2014).","journal-title":"Br. J. Cancer"},{"key":"413_CR20","doi-asserted-by":"publisher","first-page":"E10161","DOI":"10.1073\/pnas.1710680114","volume":"114","author":"J Stockis","year":"2017","unstructured":"Stockis, J. et al. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin \u03b1V\u03b28. Proc. Natl Acad. Sci. USA 114, E10161\u2013e10168 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"413_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2217\/cns.14.54","volume":"4","author":"A Hdeib","year":"2015","unstructured":"Hdeib, A. & Sloan, A. E. Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax\u00ae platform in the treatment of glioblastoma multiforme. CNS Oncol. 4, 63\u201369 (2015).","journal-title":"CNS Oncol."},{"key":"413_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1593\/neo.11024","volume":"13","author":"M Candolfi","year":"2011","unstructured":"Candolfi, M. et al. B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory\/conditionally cytotoxic therapy for glioblastoma. Neoplasia 13, 947\u2013960 (2011).","journal-title":"Neoplasia"},{"key":"413_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2326-6066.CIR-15-0313","volume":"4","author":"W Liang","year":"2016","unstructured":"Liang, W. & Ferrara, N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol. Res. 4, 83\u201391 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"413_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.4287","volume":"232","author":"J Galon","year":"2014","unstructured":"Galon, J. et al. Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours. J. Pathol. 232, 199\u2013209 (2014).","journal-title":"J. Pathol."},{"key":"413_CR25","doi-asserted-by":"publisher","first-page":"e23401","DOI":"10.4161\/onci.23401","volume":"2","author":"S Pellegatta","year":"2013","unstructured":"Pellegatta, S. et al. The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates. Oncoimmunology 2, e23401 (2013).","journal-title":"Oncoimmunology"},{"key":"413_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/cancers10120522","volume":"10","author":"I Gol\u00e1n","year":"2018","unstructured":"Gol\u00e1n, I., Rodr\u00edguez de la Fuente, L. & Costoya, J. A. NK cell-based glioblastoma immunotherapy. Cancers 10, 522 (2018).","journal-title":"Cancers"},{"key":"413_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cells10030607","volume":"10","author":"ECF Yeo","year":"2021","unstructured":"Yeo, E. C. F., Brown, M. P., Gargett, T. & Ebert, L. M. The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy. Cells 10, 607 (2021).","journal-title":"Cells"},{"key":"413_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-205","volume":"10","author":"J Galon","year":"2012","unstructured":"Galon, J. et al. Cancer classification using the Immunoscore: a worldwide task force. J. Transl. Med. 10, 205 (2012).","journal-title":"J. Transl. Med."},{"key":"413_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C. & Marini, F. C. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 18, 84 (2016).","journal-title":"Breast Cancer Res."},{"key":"413_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","volume":"16","author":"PP Santoiemma","year":"2015","unstructured":"Santoiemma, P. P. & Powell, D. J. Jr. Tumor infiltrating lymphocytes in ovarian cancer. Cancer Biol. Ther. 16, 807\u2013820 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"413_CR31","doi-asserted-by":"publisher","first-page":"688625","DOI":"10.3389\/fphar.2021.688625","volume":"12","author":"Z Tan","year":"2021","unstructured":"Tan, Z. et al. The role of tumor inflammatory microenvironment in lung cancer. Front. Pharm. 12, 688625 (2021).","journal-title":"Front. Pharm."},{"key":"413_CR32","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.3390\/cancers12123716","volume":"12","author":"R Hass","year":"2020","unstructured":"Hass, R., von der Ohe, J. & Ungefroren, H. Impact of the tumor microenvironment on tumor heterogeneity and consequences for cancer cell plasticity and stemness. Cancers 12, 3716 (2020).","journal-title":"Cancers"},{"key":"413_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"413_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"413_CR35","doi-asserted-by":"publisher","first-page":"707802","DOI":"10.3389\/fgene.2021.707802","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. An integrated analysis of tumor purity of common central nervous system tumors in children based on machine learning methods. Front. Genet. 12, 707802 (2021).","journal-title":"Front. Genet."},{"key":"413_CR36","doi-asserted-by":"publisher","first-page":"24768","DOI":"10.18632\/aging.203714","volume":"13","author":"Y Deng","year":"2021","unstructured":"Deng, Y. et al. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer. Aging 13, 24768\u201324785 (2021).","journal-title":"Aging"},{"key":"413_CR37","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391, 2128\u20132139 (2018).","journal-title":"Lancet"},{"key":"413_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"413_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","volume":"6","author":"P Danaher","year":"2018","unstructured":"Danaher, P. et al. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). J. Immunother. Cancer 6, 63 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"413_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2100-3","volume":"17","author":"D Damotte","year":"2019","unstructured":"Damotte, D. et al. The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. J. Transl. Med. 17, 357 (2019).","journal-title":"J. Transl. Med."},{"key":"413_CR41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.5858\/2004-128-1004-AOFCAI","volume":"128","author":"CH Dunphy","year":"2004","unstructured":"Dunphy, C. H. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch. Pathol. Lab Med. 128, 1004\u20131022 (2004).","journal-title":"Arch. Pathol. Lab Med."},{"key":"413_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2020.00027","volume":"14","author":"T Kurc","year":"2020","unstructured":"Kurc, T. et al. Segmentation and classification in digital pathology for glioma research: challenges and deep learning approaches. Front. Neurosci. 14, 27 (2020).","journal-title":"Front. Neurosci."},{"key":"413_CR43","doi-asserted-by":"publisher","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","volume":"11","author":"W Jiang","year":"2020","unstructured":"Jiang, W. et al. Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy. Front. Immunol. 11, 622509 (2020).","journal-title":"Front. Immunol."},{"key":"413_CR44","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","volume":"24","author":"K Woroniecka","year":"2018","unstructured":"Woroniecka, K. et al. T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma. Clin. Cancer Res. 24, 4175\u20134186 (2018).","journal-title":"Clin. Cancer Res."},{"key":"413_CR45","doi-asserted-by":"publisher","first-page":"557994","DOI":"10.3389\/fimmu.2021.557994","volume":"12","author":"B Zhao","year":"2021","unstructured":"Zhao, B. et al. Investigation of genetic determinants of glioma immune phenotype by integrative immunogenomic scale analysis. Front. Immunol. 12, 557994 (2021).","journal-title":"Front. Immunol."},{"key":"413_CR46","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/1878-0261.12707","volume":"14","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Classification of diffuse lower-grade glioma based on immunological profiling. Mol. Oncol. 14, 2081\u20132095 (2020).","journal-title":"Mol. Oncol."},{"key":"413_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12031-020-01484-0","volume":"70","author":"J Zhang","year":"2020","unstructured":"Zhang, J., Xiao, X., Zhang, X. & Hua, W. Tumor microenvironment characterization in glioblastoma identifies prognostic and immunotherapeutically relevant gene signatures. J. Mol. Neurosci. 70, 738\u2013750 (2020).","journal-title":"J. Mol. Neurosci."},{"key":"413_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.omto.2020.12.012","volume":"20","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Classification of pediatric gliomas based on immunological profiling: Implications for immunotherapy strategies. Mol. Ther. Oncolytics 20, 34\u201347 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"413_CR49","doi-asserted-by":"publisher","first-page":"e001066","DOI":"10.1136\/jitc-2020-001066","volume":"8","author":"MH Robinson","year":"2020","unstructured":"Robinson, M. H. et al. Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma. J. Immunother. Cancer 8, e001066 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"413_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/jpm10030112","volume":"10","author":"H Rahimi Koshkaki","year":"2020","unstructured":"Rahimi Koshkaki, H. et al. Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma. J. Pers. Med. 10, 112 (2020).","journal-title":"J. Pers. Med."},{"key":"413_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-019-0536-x","volume":"7","author":"L Pinton","year":"2019","unstructured":"Pinton, L. et al. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. J. Immunother. Cancer 7, 58 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"413_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11060-017-2737-9","volume":"137","author":"AS Plant","year":"2018","unstructured":"Plant, A. S. et al. Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response. J. Neurooncol. 137, 269\u2013278 (2018).","journal-title":"J. Neurooncol."},{"key":"413_CR53","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1158\/2326-6066.CIR-18-0939","volume":"7","author":"M Bockmayr","year":"2019","unstructured":"Bockmayr, M. et al. Immunologic profiling of mutational and transcriptional subgroups in pediatric and adult high-grade gliomas. Cancer Immunol. Res. 7, 1401\u20131411 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"413_CR54","doi-asserted-by":"publisher","first-page":"672928","DOI":"10.3389\/fonc.2021.672928","volume":"11","author":"X Cai","year":"2021","unstructured":"Cai, X. et al. Glioma-associated stromal cells stimulate glioma malignancy by regulating the tumor immune microenvironment. Front. Oncol. 11, 672928 (2021).","journal-title":"Front. Oncol."},{"key":"413_CR55","doi-asserted-by":"publisher","first-page":"691811","DOI":"10.3389\/fimmu.2021.691811","volume":"12","author":"N Zhang","year":"2021","unstructured":"Zhang, N. et al. Immune infiltrating cells-derived risk signature based on large-scale analysis defines immune landscape and predicts immunotherapy responses in glioma tumor microenvironment. Front. Immunol. 12, 691811 (2021).","journal-title":"Front. Immunol."},{"key":"413_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01323-w","volume":"10","author":"B Mehani","year":"2022","unstructured":"Mehani, B. et al. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology. Acta Neuropathol. Commun. 10, 19 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"413_CR57","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.cell.2020.10.044","volume":"183","author":"F Petralia","year":"2020","unstructured":"Petralia, F. et al. Integrated proteogenomic characterization across major histological types of pediatric brain cancer. Cell 183, 1962\u20131985.e31 (2020).","journal-title":"Cell"},{"key":"413_CR58","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48, 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"key":"413_CR59","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1016\/S2589-7500(22)00144-3","volume":"4","author":"P Lohmann","year":"2022","unstructured":"Lohmann, P. et al. Radiomics in neuro-oncological clinical trials. Lancet Digit. Health 4, e841\u2013e849 (2022).","journal-title":"Lancet Digit. Health"},{"key":"413_CR60","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1172\/JCI140378","volume":"130","author":"S Mueller","year":"2020","unstructured":"Mueller, S. et al. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. J. Clin. Invest. 130, 6325\u20136337 (2020).","journal-title":"J. Clin. Invest."},{"key":"413_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","volume":"13","author":"NA Vitanza","year":"2023","unstructured":"Vitanza, N. A. et al. Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety. Cancer Discov. 13, 114\u2013131 (2023).","journal-title":"Cancer Discov."},{"key":"413_CR62","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","volume":"28","author":"T Todo","year":"2022","unstructured":"Todo, T. et al. Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial. Nat. Med. 28, 1630\u20131639 (2022).","journal-title":"Nat. Med."},{"key":"413_CR63","doi-asserted-by":"crossref","unstructured":"Mattiola, I. & Diefenbach, A. in Seminars in Immunology Vol. 66, 101724 (Elsevier, 2023).","DOI":"10.1016\/j.smim.2023.101724"},{"key":"413_CR64","doi-asserted-by":"publisher","first-page":"101244","DOI":"10.18632\/oncotarget.20643","volume":"8","author":"S Narang","year":"2017","unstructured":"Narang, S. et al. Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma. Oncotarget 8, 101244\u2013101254 (2017).","journal-title":"Oncotarget"},{"key":"413_CR65","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/brain\/awab340","volume":"145","author":"G Li","year":"2022","unstructured":"Li, G. et al. An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 145, 1151\u20131161 (2022).","journal-title":"Brain"},{"key":"413_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34242-9","volume":"8","author":"HR Cho","year":"2018","unstructured":"Cho, H. R., Jeon, H., Park, C. K., Park, S. H. & Choi, S. H. Radiogenomics profiling for glioblastoma-related immune cells reveals CD49d expression correlation with MRI parameters and prognosis. Sci. Rep. 8, 16022 (2018).","journal-title":"Sci. Rep."},{"key":"413_CR67","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00262-020-02836-w","volume":"70","author":"AR Kim","year":"2021","unstructured":"Kim, A. R. et al. Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values. Cancer Immunol. Immunother. 70, 1995\u20132008 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"413_CR68","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3390\/cancers12103039","volume":"12","author":"JB Hsu","year":"2020","unstructured":"Hsu, J. B. et al. Radiomic immunophenotyping of GSEA-assessed immunophenotypes of glioblastoma and its implications for prognosis: a feasibility study. Cancers 12, 3039 (2020).","journal-title":"Cancers"},{"key":"413_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00330-022-09012-x","volume":"33","author":"D Liu","year":"2023","unstructured":"Liu, D. et al. Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma. Eur. Radio. 33, 209\u2013220 (2023).","journal-title":"Eur. Radio."},{"key":"413_CR70","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.tranon.2021.101065","volume":"14","author":"ZZ Li","year":"2021","unstructured":"Li, Z. Z. et al. Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients. Transl. Oncol. 14, 101065 (2021).","journal-title":"Transl. Oncol."},{"key":"413_CR71","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18, 248\u2013262 (2017).","journal-title":"Cell Rep."},{"key":"413_CR72","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00432-020-03153-6","volume":"146","author":"P Lin","year":"2020","unstructured":"Lin, P. et al. Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value. J. Cancer Res. Clin. Oncol. 146, 1253\u20131262 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"413_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ctro.2021.03.006","volume":"28","author":"JH Wang","year":"2021","unstructured":"Wang, J. H. et al. Radiomic biomarkers of tumor immune biology and immunotherapy response. Clin. Transl. Radiat. Oncol. 28, 97\u2013115 (2021).","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"413_CR74","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/jcm8112007","volume":"8","author":"V Cuccarini","year":"2019","unstructured":"Cuccarini, V. et al. Advanced MRI assessment during dendritic cell immunotherapy added to standard treatment against glioblastoma. J. Clin. Med. 8, 2007 (2019).","journal-title":"J. Clin. Med."},{"key":"413_CR75","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3174\/ajnr.A7488","volume":"43","author":"E George","year":"2022","unstructured":"George, E. et al. Radiomics-based machine learning for outcome prediction in a multicenter phase II study of programmed death-ligand 1 inhibition immunotherapy for glioblastoma. AJNR Am. J. Neuroradiol. 43, 675\u2013681 (2022).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"413_CR76","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/14737159.2017.1374854","volume":"17","author":"GM Shankar","year":"2017","unstructured":"Shankar, G. M., Balaj, L., Stott, S. L., Nahed, B. & Carter, B. S. Liquid biopsy for brain tumors. Expert Rev. Mol. Diagn. 17, 943\u2013947 (2017).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"413_CR77","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/0008-5472.CAN-15-1707","volume":"76","author":"R Tavar\u00e9","year":"2016","unstructured":"Tavar\u00e9, R. et al. An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy. Cancer Res 76, 73\u201382 (2016).","journal-title":"Cancer Res"},{"key":"413_CR78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00259-018-4107-z","volume":"46","author":"KR Roodakker","year":"2019","unstructured":"Roodakker, K. R. et al. Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity. Eur. J. Nucl. Med. Mol. Imaging 46, 569\u2013579 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"413_CR79","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2463\/mrms.rev.2021-0116","volume":"21","author":"M Matsumae","year":"2022","unstructured":"Matsumae, M., Nishiyama, J. & Kuroda, K. Intraoperative MR imaging during glioma resection. Magn. Reson Med. Sci. 21, 148\u2013167 (2022).","journal-title":"Magn. Reson Med. Sci."},{"key":"413_CR80","doi-asserted-by":"publisher","first-page":"e0239495","DOI":"10.1371\/journal.pone.0239495","volume":"15","author":"J Gustafsson","year":"2020","unstructured":"Gustafsson, J. et al. Sources of variation in cell-type RNA-Seq profiles. PLoS ONE 15, e0239495 (2020).","journal-title":"PLoS ONE"},{"key":"413_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18383\/j.tom.2017.00112","volume":"3","author":"S Galb\u00e1n","year":"2017","unstructured":"Galb\u00e1n, S. et al. MRI-guided stereotactic biopsy of murine GBM for spatiotemporal molecular genomic assessment. Tomography 3, 9\u201315 (2017).","journal-title":"Tomography"},{"key":"413_CR82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani, A. R. et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11, 102\u2013125 (2009).","journal-title":"Neoplasia"},{"key":"413_CR83","doi-asserted-by":"publisher","first-page":"W483","DOI":"10.2214\/AJR.12.9724","volume":"200","author":"MJ Borja","year":"2013","unstructured":"Borja, M. J., Plaza, M. J., Altman, N. & Saigal, G. Conventional and advanced MRI features of pediatric intracranial tumors: supratentorial tumors. AJR Am. J. Roentgenol. 200, W483\u2013W503 (2013).","journal-title":"AJR Am. J. Roentgenol."},{"key":"413_CR84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.12111607","volume":"264","author":"O Gevaert","year":"2012","unstructured":"Gevaert, O. et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data-methods and preliminary results. Radiology 264, 387\u2013396 (2012).","journal-title":"Radiology"},{"key":"413_CR85","doi-asserted-by":"publisher","first-page":"e23421","DOI":"10.7554\/eLife.23421","volume":"6","author":"P Grossmann","year":"2017","unstructured":"Grossmann, P. et al. Defining the biological basis of radiomic phenotypes in lung cancer. Elife 6, e23421 (2017).","journal-title":"Elife"},{"key":"413_CR86","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3171\/2015.4.JNS142732","volume":"124","author":"A Rao","year":"2016","unstructured":"Rao, A. et al. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma. J. Neurosurg. 124, 1008\u20131017 (2016).","journal-title":"J. Neurosurg."},{"key":"413_CR87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3174\/ajnr.A6358","volume":"41","author":"DJ Leao","year":"2020","unstructured":"Leao, D. J., Craig, P. G., Godoy, L. F., Leite, C. C. & Policeni, B. Response assessment in neuro-oncology criteria for gliomas: practical approach using conventional and advanced techniques. AJNR Am. J. Neuroradiol. 41, 10\u201320 (2020).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"413_CR88","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S1470-2045(20)30173-X","volume":"21","author":"C Erker","year":"2020","unstructured":"Erker, C. et al. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 21, e317\u2013e329 (2020).","journal-title":"Lancet Oncol."},{"key":"413_CR89","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.neo.2022.100846","volume":"35","author":"JV Lilly","year":"2023","unstructured":"Lilly, J. V. et al. The children\u2019s brain tumor network (CBTN)\u2014accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia 35, 100846 (2023).","journal-title":"Neoplasia"},{"key":"413_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genom. Proteom. Bioinforma. 19, 1\u201312 (2021).","journal-title":"Genom. Proteom. Bioinforma."},{"key":"413_CR91","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"VB Clark K","year":"2013","unstructured":"Clark K, V. B. et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J. Digit. Imaging 26, 1045\u20131057 (2013).","journal-title":"J. Digit. Imaging"},{"key":"413_CR92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5195\/jmla.2020.909","volume":"108","author":"L Federer","year":"2020","unstructured":"Federer, L. et al. The Medical Library Association Data Services Competency: a framework for data science and open science skills development. J. Med. Libr. Assoc. 108, 304\u2013309 (2020).","journal-title":"J. Med. Libr. Assoc."},{"key":"413_CR93","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/1078-0432.CCR-22-0803","volume":"28","author":"C Kline","year":"2022","unstructured":"Kline, C. et al. Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003. Clin. Cancer Res. 28, 3965\u20133978 (2022).","journal-title":"Clin. Cancer Res."},{"key":"413_CR94","doi-asserted-by":"publisher","first-page":"dmm040386","DOI":"10.1242\/dmm.040386","volume":"12","author":"FL Robertson","year":"2019","unstructured":"Robertson, F. L., Marqu\u00e9s-Torrej\u00f3n, M.-A., Morrison, G. M. & Pollard, S. M. Experimental models and tools to tackle glioblastoma. Dis. Model. Mech. 12, dmm040386 (2019).","journal-title":"Dis. Model. Mech."},{"key":"413_CR95","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/neuonc\/noz077","volume":"21","author":"JB Foster","year":"2019","unstructured":"Foster, J. B. et al. Immunotherapy for pediatric brain tumors: past and present. Neuro. Oncol. 21, 1226\u20131238 (2019).","journal-title":"Neuro. Oncol."},{"key":"413_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"413_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiol.13130078","volume":"270","author":"N Jamshidi","year":"2014","unstructured":"Jamshidi, N., Diehn, M., Bredel, M. & Kuo, M. D. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology 270, 1\u20132 (2014).","journal-title":"Radiology"},{"key":"413_CR98","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11060-016-2174-1","volume":"129","author":"GH Jajamovich","year":"2016","unstructured":"Jajamovich, G. H., Valiathan, C. R., Cristescu, R. & Somayajula, S. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma. J. Neurooncol. 129, 289\u2013300 (2016).","journal-title":"J. Neurooncol."},{"key":"413_CR99","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1002\/cam4.1672","volume":"7","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Molecular profiles of tumor contrast enhancement: a radiogenomic analysis in anaplastic gliomas. Cancer Med. 7, 4273\u20134283 (2018).","journal-title":"Cancer Med."},{"key":"413_CR100","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.nicl.2018.10.014","volume":"20","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin. 20, 1070\u20131077 (2018).","journal-title":"Neuroimage Clin."},{"key":"413_CR101","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1148\/radiol.2021203281","volume":"301","author":"Q Sun","year":"2021","unstructured":"Sun, Q. et al. Biologic pathways underlying prognostic radiomics phenotypes from paired MRI and RNA sequencing in glioblastoma. Radiology 301, 654\u2013663 (2021).","journal-title":"Radiology"},{"key":"413_CR102","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00066-020-01584-1","volume":"196","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas. Strahlenther. Onkol. 196, 913\u2013921 (2020).","journal-title":"Strahlenther. Onkol."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00413-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00413-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00413-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T03:05:47Z","timestamp":1687143947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-023-00413-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1038\/s41698-023-00413-9","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}